Shaolin Capital Management’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Shaolin Capital Management’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-116,666	Closed	-$88K	–	962
2022 Q3	$88K	Hold	116,666	–	–	﹤0.01%	514
2022 Q2	$9K	Buy	+116,666	New	+$20.3K	﹤0.01%	925

Shaolin Capital Management's FLACW Position: Q4 2022 in Review

Shaolin Capital Management sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 116,666 shares — an estimated $88K sold.

Shaolin Capital Management first reported a position in FLACW in Q2 2022 and held it in 2 quarters. The position peaked at $88K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

Shaolin Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Shaolin Capital Management sold 116,666 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $88K.
Shaolin Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q2 2022 and held it in 2 quarters.
Shaolin Capital Management's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $88K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on Shaolin Capital Management's 13F filing for Q4 2022, filed 15 Feb 2023.